WHO Names New African Variant ‘Omicron’: What We Know So Far, the Recommendations, Where India Stands

Early in the morning into the pandemic of Covid-19, the world races Friday to load the new Coronavirus variant – B.1.1.529 – Potentially more dangerous than those who have triggered a wave of nonstop infections in almost every continent. The World Health Organization Panel named the “Omicron” variant and classified it as a very transmitting virus, the same category that includes the dominant Delta variant, which is still a specter riding cases of disease and death in Europe and parts of the United States.

The actual risk of Omicron has not been understood. But initial evidence shows that it brings an increased risk of reinfection compared to other very contagious variants, WHO said. That means people who sign covid-19 and recover can be returned again. It takes weeks to find out whether the vaccine is currently less effective against it.

As a number of countries – the United States, Canada, Russia – limit the journey for visitors from the region, this is what the international health agency has been said to now about the variant  WHO Panel – Technical Advisory Group about the evolution of the SARS-COV-2 virus – repeated on November 26 to assess the new Covid-19 variant named the letter in the Greek Alfab
Et.

Which marks a different peak in the case reported in South Africa. Of the more than 200 new cases confirmed per day in the past few weeks, the area has seen the number of new daily rocket cases to 2,465 on Thursday. Struggling to explain a sudden increase in cases, scientists studied the sample virus from the plague and found a new variant. Infection B.1.1.529 The first known confirmed comes from the specimens collected on November 9, 2021, reports with the body’s health  Variants have a large number of mutations, some of them are concerned, which says, adding that in accordance with the initial evidence, increased risk of reinfection is assumed to this variant, compared to other ‘variants of concern’.

The number of cases of this variant seems to increase in almost all provinces in South Africa. The Diagnostic PCR SARS-COV-2 currently continues to detect this variant. Some laboratories have indicated that for one PCR test that is widely used, one of the three target genes is not detected (called Gene Dropout or failed to target genes) and therefore this test can be used as a marker for this variant, confirm the delayed sequence. By using this approach, this variant has been detected at a faster level than a surge in previous infection, indicating that this variant may have a growth advantage, which has been said.

• Panels also recommend a number of steps that must be followed by countries after this Sordid discovery:

‣ Increase supervision and sequencing efforts to better understand the circulating variant of SARS-COV-2.

‣ Send complete genome sequences and related metadata to the public database, such as GISAID. GISAID is a global science initiative and the main source founded in 2008 which provides open access to the data of the Influenza and Covid-19 Coronavirus virus genome. The first order of the first SARS-COV-2 genome was available in GISAID on January 10, 2020, allowing a global response to a pandemic, including the development of the first vaccine and diagnostic test to detect SARS-COV-2.

‣ Report the initial cases / clusters related to the VOC infection to whom through the IHR mechanism. International health regulations are international legal instruments who legally bind in 196 countries, including 194 member countries. IHR grew from a response to a deadly epidemic that once invaded Europe where the capacity exists and in coordination with the international community, conducting field investigations and laboratory assessments to improve the understanding of the potential impact of VOC in Covid-19 epidemiology, severity, public health effectiveness and social action, “immune response, neutrali antibodies